The market can sell a generator faster than a physician can become proficient.
Thyroid ablation is expanding rapidly. That growth is clinically valuable only when advanced ultrasound skill, patient selection, proctoring and outcomes review develop alongside device adoption.
Primary safety system
Ultrasound expertise governs anatomy, applicator visibility, hydrodissection and treatment margins.
Required competencies
Diagnostic ultrasound, interventional ultrasound and oncologic ultrasound are distinct but overlapping capabilities.
Documented learning curves
Published studies identify improvement from the first 20 cases through approximately 50–66 or more, depending on the endpoint and training environment.
Universal case threshold
No single published number proves competence. Case quality, supervision, outcomes and scope matter.
Thyroid ablation is an ultrasound procedure before it is an energy procedure.
Radiofrequency, microwave, laser and pulsed-field systems use different forms of energy. From the physician’s perspective, each depends on the same central instrument: real-time ultrasound.
Ultrasound determines what the lesion is, whether its boundaries are visible, where the applicator enters, whether the full applicator is continuously tracked, where critical structures are located, whether protective fluid planes remain intact and whether the viable margin has been completely treated.
The American Thyroid Association’s consensus statement is organized around safe implementation, the optimal skill set for proceduralists and realistic expectations of success. The European Thyroid Association likewise emphasizes cervical ultrasound anatomy, image-guided diagnostic experience and dedicated therapeutic training.1, 2
The generator delivers energy. The physician determines where that energy goes—and whether it should be delivered at all.
The three ultrasound competencies
Diagnostic ultrasound
The physician must be able to conduct or independently interpret a complete thyroid and cervical examination.
- Nodule composition, echogenicity and margins
- Calcification and vascular patterns
- Extrathyroidal relationships
- Cervical lymph-node mapping
- Malignancy-risk stratification
- Recognition of lesions unsuitable for ablation
Interventional ultrasound
Competence means continuous control—not occasionally seeing the needle or antenna.
- In-plane access and trans-isthmic planning
- Continuous applicator visualization
- Moving-shot or equivalent technique
- Hydrodissection creation and maintenance
- Marginal-vessel control
- Recognition of residual viable tissue
Oncologic ultrasound
Cancer, recurrence and metastatic nodes demand a separate level of staging and margin judgment.
- Cervical compartment anatomy
- Tumor-capsule relationships
- Extrathyroidal extension
- Previously operated necks
- Curative versus palliative objectives
- Post-ablation surveillance and salvage planning
The danger is measured in millimeters.
There is little room for imprecision.
The 2025 Korean guideline for recurrent thyroid cancer emphasizes high-resolution ultrasound, nerve anatomy, small active tips and hydrodissection. Previously operated anatomy can displace or obscure the recurrent laryngeal nerve and raise the risk of thermal injury.3
Hydrodissection is not a decorative technical refinement. In difficult anatomy, it creates a temporary protective plane between the target and vulnerable structures. The physician must also recognize when the plane is inadequate, when it has dissipated and when the procedure should stop.
A manufacturer certificate confirms attendance—not mastery.
What a good company course can provide
- Generator setup and controls
- Electrode or antenna selection
- Cooling and grounding workflow
- Standard energy ranges
- Phantom practice
- Demonstration of access and moving-shot technique
- Connection to experienced physician mentors
What a short course cannot establish
- Independent cervical diagnostic competence
- Complex danger-zone anatomy
- Appropriate modality selection
- Nerve rescue or airway management
- Complete marginal treatment
- Cancer and recurrence competency
- Long-term outcome interpretation
A 2025 systematic review of thyroid biopsy and ablation training programs supports the integration of simulation-based learning and supervised procedural experience. The evidence base remains heterogeneous, reinforcing the need to judge programs by their structure and assessment rather than by the existence of a certificate.9
Training on a device teaches the physician how the device operates. Clinical competence requires knowing what to do before, during and after energy delivery.
The learning curve is real—and it does not end after one workshop.
Published studies use different operators, endpoints and practice environments. They therefore do not produce one universal minimum case number. They consistently show that experience affects treatment performance.
One CUSUM analysis identified an initial phase at cases 1–20, a consolidation phase at cases 21–65 and a proficiency phase beginning at case 66.5 Another study comparing cases 1–30, 31–60 and 61–90 reported improvement across chronological experience groups.6
The 2025 Dutch RATED registry found a measurable learning curve during the first 20 cases per center. Median 12-month volume reduction rose from 60.4% in the early cases to 70.8% after those cases were excluded. The authors noted that this learning curve was shorter than earlier reports, likely reflecting structured implementation in experienced referral centers.7
A six-stage RFAMD competency pathway
This is an editorial framework for discussion—not a regulatory credential, board certification or professional-society guideline.
- Comprehensive thyroid ultrasound
- Cervical lymph-node mapping
- Malignancy-risk stratification
- Ultrasound-guided biopsy
- Recognition of cases unsuitable for ablation
Suggested scope progression
| Practice stage | Appropriate early scope | Should remain restricted |
|---|---|---|
| Proctored beginner | Clearly benign, well-visualized, moderate anterior nodules separated from critical structures. | Posterior danger-zone lesions, cancer, recurrence, metastatic nodes and distorted surgical beds. |
| Independent benign practice | Benign solid, cystic-solid and selected autonomous nodules with formal outcome review. | Cancer unless separately trained, proctored and institutionally supported. |
| Advanced oncologic practice | Selected primary cancer, recurrent disease or metastatic nodes after separate advanced preparation. | Cases without complete staging, achievable margins, multidisciplinary review or salvage planning. |
The low-volume physician problem
A physician may complete training and purchase a device but receive few patients. This is a clinical problem as well as a financial one.
Skill development
Infrequent procedures limit repetition, feedback and the ability to progress through the learning curve.
Outcome blindness
Without systematic follow-up, the physician may miss undertreated margins, regrowth, repeat-procedure burden or weak volume reduction.
Device bias
Financial commitment to one platform may encourage the physician to fit patients to the device rather than select the best modality.
Minimum outcomes dashboard
| Measure | Why it matters |
|---|---|
| Initial ablation ratio | Early marker of how completely the viable target was treated. |
| Volume-reduction ratio | Objective outcome at standardized follow-up intervals. |
| Technique efficacy | Whether the procedure achieved the program’s predefined success threshold. |
| Voice change and other complications | Safety must be recorded, including transient events. |
| Retreatment and regrowth | Immediate technical success is not the same as durable disease control. |
| Referral to surgery or another modality | Shows whether the program can recognize its own limits. |
Long-term research also demonstrates that the initial ablation ratio predicts later volume reduction and retreatment, reinforcing the importance of complete treatment and structured follow-up.11
A safe center is more than a physician and a generator.
Clinical infrastructure
- High-resolution ultrasound
- Thyroid-specific applicators
- Hydrodissection supplies
- Voice-monitoring protocol
- Standardized biopsy and pathology access
Emergency capability
- Hematoma response
- Airway plan
- Laryngoscopy access
- Nerve-injury protocol
- Transfer or surgical backup
Multidisciplinary system
- Endocrinology
- Endocrine or head-and-neck surgery
- Nuclear medicine
- Radiation and medical oncology when needed
- Longitudinal outcome registry
Questions that reveal more than the device brand
A physician should be willing to answer these questions with data—not reassurance alone.
Hospitals should credential the scope—not merely the device.
Credentialing should not rest solely on licensure, completion of a company course, ownership of an FDA-cleared generator or privileges for another needle procedure.
Credentialing evidence
- Thyroid ultrasound experience
- Biopsy competence
- Simulation and hands-on education
- Proctored clinical cases
- Defined lesion categories
- Continuing volume and outcomes
- Complication-management capability
Graduated privileges
- Benign-nodule ablation
- Autonomous-nodule treatment
- Large or complex nodules
- Primary low-risk cancer
- Recurrent thyroid-bed disease
- Metastatic lymph nodes
These categories should not automatically be combined into one undifferentiated “thyroid ablation” privilege.
The field should stop asking only which machine the physician bought.
It should ask what the physician can see, interpret and control under ultrasound.
The most advanced generator cannot correct a missed suspicious lymph node, an incorrectly diagnosed lesion, a poorly visualized applicator, an absent hydrodissection plane, an untreated viable margin or a physician who does not recognize when surgery is preferable.
Manufacturer education can begin the process. Competence requires diagnostic ultrasound, procedural skill, simulation, proctoring, volume, outcome review, complication management and the judgment to decline inappropriate cases.
The generator is an energy source. Ultrasound skill is the safety system.
The best thyroid-ablation program is not defined by the logo on its generator. It is defined by the quality of its imaging, the judgment of its physicians and its willingness to recommend the right treatment—even when that treatment occurs somewhere else.
About this report
Philip James
Medical Journalist and Victim of Unnecessary Thyroid Surgery
This report is not an argument for ablation in every patient. It is an argument for rigorous diagnosis, high-level ultrasound, structured training, transparent outcomes and treatment selected according to the disease—not according to the machine a clinic owns.
Methodology
RFAMD reviewed professional-society guidance, peer-reviewed learning-curve studies, training literature, complication research and outcome studies relevant to ultrasound-guided thyroid ablation. The six-stage pathway is an RFAMD editorial proposal intended to support discussion. It is not a formal credential, regulation or professional-society standard.
References
- Sinclair CF, et al. General Principles for the Safe Performance, Training, and Adoption of Ablation Techniques for Benign Thyroid Nodules: An American Thyroid Association Statement. Thyroid. 2023.
- Papini E, et al. 2020 European Thyroid Association Clinical Practice Guideline for the Use of Image-Guided Ablation in Benign Thyroid Nodules.
- Ha EJ, et al. Radiofrequency Ablation for Recurrent Thyroid Cancers: 2025 Korean Society of Thyroid Radiology Guideline.
- Novel and Advanced Ultrasound Techniques for Thyroid Thermal Ablation. 2024.
- Learning curve analysis of radiofrequency ablation for benign thyroid nodules.
- Learning curve for radiofrequency ablation of benign thyroid nodules.
- Braak SJ, et al. Radiofrequency Ablation for Thyroid Nodules (RATED Study)—Analysis of a Learning Curve and Predictors of Success. JCEM. 2025.
- Li Y-R, et al. Successful Applications of Food-Assisted and -Simulated Training Model of Thyroid Radiofrequency Ablation. 2022.
- Training Programs for Thyroid Biopsy and Ablation: A Systematic Review. 2025.
- Baek JH, et al. Complications encountered in the treatment of benign thyroid nodules with US-guided radiofrequency ablation: a multicenter study.
- Initial Ablation Ratio Predicts Volume Reduction and Retreatment After 5 Years From Radiofrequency Ablation of Benign Thyroid Nodules.
- A novel guided approach to radiofrequency ablation of thyroid nodules: the Toronto Sunnybrook experience.